Valuation: Medicure Inc.

Market Cap 13.46M 9.5M 8.31M 7.67M 7.09M 907M 13.69M 91.81M 35.99M 445M 35.67M 34.9M 1.54B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 10.52M 7.42M 6.5M 5.99M 5.54M 709M 10.69M 71.73M 28.12M 348M 27.87M 27.27M 1.21B EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day+0.78%
1 month+24.04%
3 months+5.74%
6 months+3.20%
Current year+13.16%
1 month 1
Extreme 1
1.29
Current year 0.85
Extreme 0.85
1.35
1 year 0.85
Extreme 0.85
1.43
3 years 0.63
Extreme 0.63
1.8
5 years 0.63
Extreme 0.63
1.8
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 15/09/1997
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2019
Director TitleAgeSince
Chairman 79 15/09/1997
Director/Board Member 92 28/02/2000
Director/Board Member 56 22/01/2013
Date Insider Type Main position Quantity % Market Cap.
06-22Buy

Chief Executive Officer

2,500 0.0240%
06-22Buy

Chief Executive Officer

1,000 0.0096%
06-22Buy

Chief Executive Officer

200 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%-.--%+4.88%+12.17% 9.49M
-0.38%-3.44%+71.35%+126.62% 56.71B
+4.91%-3.30%+71.97%+92.14% 51.3B
+1.42%+5.94%+22.56%+479.56% 25.26B
-0.53%-4.61%-16.76%-13.39% 23.65B
+3.93%+7.11%+44.20%-1.96% 18.69B
+2.01%+2.99%+40.72%-24.46% 17.71B
-6.84%+4.81%+201.88%+348.11% 17.7B
-0.92%+8.90%+38.48% - 14.26B
+1.28%+1.74%+28.93%+197.95% 14.1B
Average +0.55%+3.10%+50.82%+135.20% 23.94B
Weighted average by Cap. +1.02%+2.16%+58.44%+142.97%

Financials

2024 2025
Net sales 21.91M 15.46M 13.53M 12.47M 11.54M 1.48B 22.27M 149M 58.56M 725M 58.05M 56.79M 2.51B 28.86M 20.37M 17.82M 16.43M 15.2M 1.94B 29.34M 197M 77.13M 955M 76.46M 74.81M 3.31B
Net income -1.04M -733K -642K -592K -547K -70M -1.06M -7.09M -2.78M -34.38M -2.75M -2.69M -119M -7.1M -5.01M -4.38M -4.04M -3.74M -478M -7.22M -48.4M -18.97M -235M -18.81M -18.4M -813M
Net Debt -6.32M -4.46M -3.9M -3.6M -3.33M -426M -6.42M -43.08M -16.89M -209M -16.74M -16.38M -724M -2.94M -2.08M -1.82M -1.68M -1.55M -198M -2.99M -20.08M -7.87M -97.4M -7.8M -7.63M -337M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume